Pathologically Proven Gadolinium-enhanced MRI Lesions in the Bilateral Corticospinal Tracts in Lymphomatosis Cerebri.
corticospinal tracts
diffuse large B-cell lymphoma
gadolinium-enhanced lesions
lymphomatosis cerebri
pathological findings
recurrence
Journal
Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241
Informations de publication
Date de publication:
15 Nov 2020
15 Nov 2020
Historique:
pubmed:
28
7
2020
medline:
15
4
2021
entrez:
28
7
2020
Statut:
ppublish
Résumé
A 78-year-old woman in complete remission of mass-forming primary central nervous system lymphoma (PCNSL) showed diffuse leukoencephalopathy as well as corticospinal tract lesions with intense gadolinium enhancement on magnetic resonance imaging (MRI). She died 3 months later. In line with the MRI findings, pathological examination revealed dense infiltration of atypical lymphoid cells, consistent with a diagnosis of lymphomatosis cerebri (LC)-type PCNSL. This is the first report of LC in which the corticospinal tracts demonstrated robust contrast enhancement directly corresponding to the neuropathological findings, and it is also a rare instance in which LC presented as a recurrence of typical PCNSL.
Identifiants
pubmed: 32713909
doi: 10.2169/internalmedicine.4382-19
pmc: PMC7725641
doi:
Substances chimiques
Contrast Media
0
Gadolinium
AU0V1LM3JT
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2931-2934Références
Crit Rev Oncol Hematol. 2017 May;113:97-110
pubmed: 28427529
Intern Med. 2015;54(12):1547-52
pubmed: 26073248
Neuroradiology. 1996 Jan;38(1):34-7
pubmed: 8773272
Neuro Oncol. 2016 May;18(5):707-15
pubmed: 26415875
Clin Cancer Res. 2004 Sep 1;10(17):5643-6
pubmed: 15355887
J Neurooncol. 2014 Mar;117(1):161-5
pubmed: 24481997
Oncol Lett. 2018 Aug;16(2):1463-1474
pubmed: 30008825
Neurol Med Chir (Tokyo). 1995 Jun;35(6):360-3
pubmed: 7566377
J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):238-40
pubmed: 24847165
Intern Med. 2012;51(9):1103-6
pubmed: 22576396
Neuro Oncol. 2017 Mar 1;19(3):422-429
pubmed: 27994065